Ignite Creation Date:
2025-12-26 @ 11:08 AM
Ignite Modification Date:
2026-02-22 @ 7:22 PM
Study NCT ID:
NCT03692312
Status:
COMPLETED
Last Update Posted:
2025-10-08
First Post:
2018-03-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy
Sponsor:
AMO Pharma Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AMO-02-MD-2-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None